NKTR - ネクタ―・セラピュ―ティクス （Nektar Therapeutics）

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Nektar Therapeutics (Nasdaq: NKTR) concerning the Company and its directors’ and officers’ possible violations of state laws. If you own Nektar Therapeutics stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169

Nektar Therapeutics (NASDAQ:NKTR) closed Tuesday at $2.27 per share, up from $2.24 a day earlier. While Nektar Therapeutics has overperformed by 1.34%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NKTR fell by -79.27%, with highs and lows ranging from $11.59 to $1.99, whereas the simple […]

The share price of Nektar Therapeutics (NASDAQ:NKTR) rose to $2.42 per share on Tuesday from $2.36. While Nektar Therapeutics has overperformed by 2.54%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NKTR fell by -80.91%, with highs and lows ranging from $12.76 to $1.99, whereas the […]

In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 1.07 million shares changing hands with its beta currently measuring 1.04. Company’s recent per share price level of $2.42 trading at $0.03 or 1.26% at ring of the bell on the day assigns it a market valuation of $442.76M. That closing price of NKTR’s stock is at … Nektar Therapeutics (NASDAQ:NKTR) 10.00% Up Over The Last Seven Days. Can The Stock Hit Well Above $0.22? Read More »

Nektar Therapeutics (NASDAQ:NKTR) concluded the trading at $2.39 on Thursday, January 05 with a rise of 2.14% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.34 and 5Y monthly beta was reading 1.18 with its price kept floating in the range … Nektar Therapeutics (NKTR) Stock Behavior Is Not Predictable Read More »

The share price of Nektar Therapeutics (NASDAQ:NKTR) rose to $2.07 per share on Wednesday from $2.03. While Nektar Therapeutics has overperformed by 1.97%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NKTR fell by -86.24%, with highs and lows ranging from $15.42 to $1.99, whereas the […]

In last trading session, Nektar Therapeutics (NASDAQ:NKTR) saw 1.46 million shares changing hands with its beta currently measuring 0.97. Company’s recent per share price level of $2.70 trading at -$0.04 or -1.46% at ring of the bell on the day assigns it a market valuation of $525.64M. That closing price of NKTR’s stock is at … Nektar Therapeutics (NASDAQ:NKTR) Reduces -6.90% In A Week: What’s Lifting The Stock? Read More »

Nektar Therapeutics (NASDAQ:NKTR) closed Tuesday at $3.43 per share, up from $3.36 a day earlier. While Nektar Therapeutics has overperformed by 2.08%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NKTR fell by -70.23%, with highs and lows ranging from $15.94 to $2.96, whereas the simple […]

Once bearish sentiment ends, good quality biotech stocks will bounce back, but Nektar Therapeutics probably won''t.

In the last trading session, 2.38 million shares of the Nektar Therapeutics (NASDAQ:NKTR) were traded, and its beta was 1.08. Most recently the company’s share price was $3.92, and it changed around -$0.16 or -3.92% from the last close, which brings the market valuation of the company to $669.61M. NKTR currently trades at a discount … An Analysis Of Nektar Therapeutics (NASDAQ: NKTR), And Its Business Forecast Read More »

As of Monday, Nektar Therapeutics’s (NASDAQ:NKTR) stock closed at $3.55, up from $3.53 the previous day. While Nektar Therapeutics has overperformed by 0.57%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NKTR fell by -79.14%, with highs and lows ranging from $17.91 to $2.96, whereas the […]

WASHINGTON (dpa-AFX) - Nektar Therapeutics has mutually agreed with PureTech Health plc to terminate talks regarding a potential business combination. Nektar reserves the right to make or particip…

PureTech Health plc (NASDAQ: PRTC ) has confirmed that it is in talks about a possible tie-up with Nektar Therapeutics (NASDAQ: NKTR ). In April, Nektar Therapeutics announced a new strategic plan to prioritize key research and development efforts and cut 70% of its workforce, including Full story available on Benzinga.com

PureTech Health (PRTC) dropped 20% in premarket trading after it confirmed receiving a non-binding proposal from Nektar Therapeutics (NKTR) to combine.PureTech and Nektar remain…

During the last session, Nektar Therapeutics (NASDAQ:NKTR)’s traded shares were 1.42 million, with the beta value of the company hitting 1.21. At the end of the trading day, the stock’s price was $3.38, reflecting an intraday gain of 0.60% or $0.02. The 52-week high for the NKTR share is $17.91, that puts it down -429.88 … After A 11.18% Jump In The Last Week, Does Nektar Therapeutics (NASDAQ: NKTR) Still Make Sense To Buy? Read More »